Alternatives to Biogen

Global biopharmaceutical company focused on oncology, rare diseases, and neuroscience.

Developing novel therapies for neurological disorders.

Developing novel therapeutics for neurodegenerative diseases using advanced biological insights.

Global pharmaceutical company focused on developing and manufacturing medicines.

Developing a novel therapeutic approach for neurological disorders using advanced neuroimaging and AI.

Prophet Bio is a biotech startup focused on developing novel therapeutics for neurodegenerative diseases.

A global pharmaceutical and biotechnology corporation developing innovative medicines and vaccines for various therapeutic areas.

Sobi is a specialized international biopharmaceutical company focused on developing innovative therapies for rare diseases.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Leveraging the adaptive immune system to diagnose and treat disease.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Biotechnology company focused on developing treatments for rare metabolic diseases.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Biopharmaceutical company developing transformative therapies for rare metabolic diseases, focusing on hyperinsulinism.

Gene therapy company developing treatments for rare inherited diseases.

Biopharmaceutical company developing antibody therapeutics for cancer and autoimmune diseases.

Alto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions.

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

Lutris Pharma is a biotechnology company focused on developing novel therapies for rare genetic diseases.

Biopharmaceutical company focused on rare genetic diseases of obesity.

Develops advanced gene editing and cell therapy solutions for rare genetic diseases.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

A global oncology company developing and commercializing innovative cancer treatments.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

A pharmaceutical company focused on developing novel therapies for complex diseases.

Developing engineered biologics to harness the immune system for disease treatment.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Clinical-stage biopharmaceutical company developing gene therapies for rare genetic diseases.

Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Ophthalmic pharmaceutical company developing novel treatments for ocular diseases.

AI-powered platform for personalized cell therapy development and manufacturing.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Develops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Biotech company developing next-generation gene writing tools for advanced therapies.

Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

Biotechnology company developing novel immunotherapies for cancer.

Gene therapy company developing transformative treatments for severe genetic diseases.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

Leap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

Biopharmaceutical company developing novel cancer therapies using targeted protein degradation.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

Clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.

Developing novel therapeutics for challenging diseases using advanced biological insights.

Develops and manufactures biologics for therapeutic applications.

Biotech company focused on developing therapies to extend human healthspan and lifespan.

Global marketplace connecting researchers with human biospecimens for life science research.

Metly empowers pharma companies to accelerate product launches through intelligent opportunity detection and partner matching.

Developing advanced cell culture media and bioprocessing solutions for cell and gene therapy.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.